Health
Biogen Alzheimer’s Drug Trial Update
A mid-stage trial of Biogen's Alzheimer’s drug showed promising results, slowing cognitive decline at rates comparable to existing treatments.
Coverage timeline — 1 article
STAT News
An Alzheimer’s drug from Biogen slowed cognitive decline in a mid-stage trial at roughly comparable rates as approved medicines
2026-07-15 13:06 UTC